ROCHE HOLDING AG-BR (RHO.DE) Fundamental Analysis & Valuation

FRA:RHO • CH0012032113

Current stock price

361.2 EUR
+2.6 (+0.73%)
Last:

This RHO.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. RHO.DE Profitability Analysis

1.1 Basic Checks

  • RHO had positive earnings in the past year.
  • RHO had a positive operating cash flow in the past year.
  • Each year in the past 5 years RHO has been profitable.
  • Each year in the past 5 years RHO had a positive operating cash flow.
RHO.DE Yearly Net Income VS EBIT VS OCF VS FCFRHO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • With a decent Return On Assets value of 12.79%, RHO is doing good in the industry, outperforming 76.92% of the companies in the same industry.
  • The Return On Equity of RHO (38.10%) is better than 84.62% of its industry peers.
  • The Return On Invested Capital of RHO (22.75%) is better than 90.38% of its industry peers.
  • RHO had an Average Return On Invested Capital over the past 3 years of 22.13%. This is above the industry average of 17.75%.
  • The 3 year average ROIC (22.13%) for RHO is below the current ROIC(22.75%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.79%
ROE 38.1%
ROIC 22.75%
ROA(3y)11.21%
ROA(5y)12.56%
ROE(3y)34.46%
ROE(5y)40.93%
ROIC(3y)22.13%
ROIC(5y)22.61%
RHO.DE Yearly ROA, ROE, ROICRHO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • RHO has a better Profit Margin (20.94%) than 75.00% of its industry peers.
  • In the last couple of years the Profit Margin of RHO has declined.
  • RHO has a Operating Margin of 34.41%. This is amongst the best in the industry. RHO outperforms 80.77% of its industry peers.
  • RHO's Operating Margin has been stable in the last couple of years.
  • RHO has a better Gross Margin (73.62%) than 61.54% of its industry peers.
  • RHO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.41%
PM (TTM) 20.94%
GM 73.62%
OM growth 3Y3.59%
OM growth 5Y1.47%
PM growth 3Y2.18%
PM growth 5Y-3.1%
GM growth 3Y1.57%
GM growth 5Y0.32%
RHO.DE Yearly Profit, Operating, Gross MarginsRHO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. RHO.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RHO is creating value.
  • The number of shares outstanding for RHO remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for RHO has been reduced compared to 5 years ago.
  • Compared to 1 year ago, RHO has an improved debt to assets ratio.
RHO.DE Yearly Shares OutstandingRHO.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
RHO.DE Yearly Total Debt VS Total AssetsRHO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 4.53 indicates that RHO is not in any danger for bankruptcy at the moment.
  • RHO has a Altman-Z score of 4.53. This is in the better half of the industry: RHO outperforms 65.38% of its industry peers.
  • The Debt to FCF ratio of RHO is 2.90, which is a good value as it means it would take RHO, 2.90 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 2.90, RHO is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
  • A Debt/Equity ratio of 0.85 indicates that RHO is somewhat dependend on debt financing.
  • RHO has a Debt to Equity ratio (0.85) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 2.9
Altman-Z 4.53
ROIC/WACC4.71
WACC4.83%
RHO.DE Yearly LT Debt VS Equity VS FCFRHO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that RHO should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.38, RHO is in line with its industry, outperforming 51.92% of the companies in the same industry.
  • RHO has a Quick Ratio of 1.12. This is a normal value and indicates that RHO is financially healthy and should not expect problems in meeting its short term obligations.
  • RHO has a Quick ratio (1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.12
RHO.DE Yearly Current Assets VS Current LiabilitesRHO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

5

3. RHO.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.41% over the past year.
  • RHO shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.49% yearly.
  • The Revenue has been growing slightly by 1.69% in the past year.
  • RHO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.07% yearly.
EPS 1Y (TTM)4.41%
EPS 3Y-1.11%
EPS 5Y0.49%
EPS Q2Q%-0.47%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y-0.94%
Revenue growth 5Y1.07%
Sales Q2Q%-0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.38% on average over the next years. This is quite good.
  • Based on estimates for the next years, RHO will show a small growth in Revenue. The Revenue will grow by 4.63% on average per year.
EPS Next Y5.01%
EPS Next 2Y6%
EPS Next 3Y6.61%
EPS Next 5Y8.38%
Revenue Next Year1.49%
Revenue Next 2Y2.67%
Revenue Next 3Y3.34%
Revenue Next 5Y4.63%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RHO.DE Yearly Revenue VS EstimatesRHO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
RHO.DE Yearly EPS VS EstimatesRHO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

5

4. RHO.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.95, RHO is valued correctly.
  • 61.54% of the companies in the same industry are more expensive than RHO, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.60. RHO is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 16.14, RHO is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of RHO indicates a somewhat cheap valuation: RHO is cheaper than 69.23% of the companies listed in the same industry.
  • RHO is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.95
Fwd PE 16.14
RHO.DE Price Earnings VS Forward Price EarningsRHO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 63.46% of the companies in the same industry are more expensive than RHO, based on the Enterprise Value to EBITDA ratio.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as RHO.
Industry RankSector Rank
P/FCF 24.69
EV/EBITDA 12.55
RHO.DE Per share dataRHO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RHO does not grow enough to justify the current Price/Earnings ratio.
  • RHO has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.39
PEG (5Y)34.89
EPS Next 2Y6%
EPS Next 3Y6.61%

4

5. RHO.DE Dividend Analysis

5.1 Amount

  • RHO has a Yearly Dividend Yield of 3.14%.
  • Compared to an average industry Dividend Yield of 1.95, RHO pays a bit more dividend than its industry peers.
  • RHO's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
RHO.DE Yearly Dividends per shareRHO.DE Yearly Dividends per shareYearly Dividends per share 2019 2026 2 4 6 8

5.3 Sustainability

  • 65.10% of the earnings are spent on dividend by RHO. This is not a sustainable payout ratio.
DP65.1%
EPS Next 2Y6%
EPS Next 3Y6.61%
RHO.DE Yearly Income VS Free CF VS DividendRHO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B
RHO.DE Dividend Payout.RHO.DE Dividend Payout, showing the Payout Ratio.RHO.DE Dividend Payout.PayoutRetained Earnings

RHO.DE Fundamentals: All Metrics, Ratios and Statistics

ROCHE HOLDING AG-BR

FRA:RHO (4/2/2026, 7:00:00 PM)

361.2

+2.6 (+0.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners41.39%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap292.30B
Revenue(TTM)61.52B
Net Income(TTM)12.88B
Analysts70.37
Price Target400.71 (10.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP65.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)14.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.29%
EPS NY rev (3m)-0.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE 16.95
Fwd PE 16.14
P/S 4.38
P/FCF 24.69
P/OCF 14.28
P/B 7.97
P/tB 38.53
EV/EBITDA 12.55
EPS(TTM)21.31
EY5.9%
EPS(NY)22.37
Fwd EY6.19%
FCF(TTM)14.63
FCFY4.05%
OCF(TTM)25.29
OCFY7%
SpS82.51
BVpS45.34
TBVpS9.37
PEG (NY)3.39
PEG (5Y)34.89
Graham Number147.44
Profitability
Industry RankSector Rank
ROA 12.79%
ROE 38.1%
ROCE 29.12%
ROIC 22.75%
ROICexc 22.75%
ROICexgc 35.66%
OM 34.41%
PM (TTM) 20.94%
GM 73.62%
FCFM 17.73%
ROA(3y)11.21%
ROA(5y)12.56%
ROE(3y)34.46%
ROE(5y)40.93%
ROIC(3y)22.13%
ROIC(5y)22.61%
ROICexc(3y)25.61%
ROICexc(5y)26.63%
ROICexgc(3y)43.58%
ROICexgc(5y)44.87%
ROCE(3y)28.23%
ROCE(5y)30.35%
ROICexgc growth 3Y-9.11%
ROICexgc growth 5Y-6.78%
ROICexc growth 3Y-8.02%
ROICexc growth 5Y-4.97%
OM growth 3Y3.59%
OM growth 5Y1.47%
PM growth 3Y2.18%
PM growth 5Y-3.1%
GM growth 3Y1.57%
GM growth 5Y0.32%
F-Score7
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 2.9
Debt/EBITDA 1.21
Cap/Depr 293.21%
Cap/Sales 12.92%
Interest Coverage 17.8
Cash Conversion 78.95%
Profit Quality 84.67%
Current Ratio 1.38
Quick Ratio 1.12
Altman-Z 4.53
F-Score7
WACC4.83%
ROIC/WACC4.71
Cap/Depr(3y)191.25%
Cap/Depr(5y)158.91%
Cap/Sales(3y)9.7%
Cap/Sales(5y)8.71%
Profit Quality(3y)122.16%
Profit Quality(5y)118.22%
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3Y-1.11%
EPS 5Y0.49%
EPS Q2Q%-0.47%
EPS Next Y5.01%
EPS Next 2Y6%
EPS Next 3Y6.61%
EPS Next 5Y8.38%
Revenue 1Y (TTM)1.69%
Revenue growth 3Y-0.94%
Revenue growth 5Y1.07%
Sales Q2Q%-0.24%
Revenue Next Year1.49%
Revenue Next 2Y2.67%
Revenue Next 3Y3.34%
Revenue Next 5Y4.63%
EBIT growth 1Y5.38%
EBIT growth 3Y2.62%
EBIT growth 5Y2.56%
EBIT Next Year21.68%
EBIT Next 3Y10.65%
EBIT Next 5Y12.14%
FCF growth 1Y-27.7%
FCF growth 3Y-6.29%
FCF growth 5Y-1.69%
OCF growth 1Y-6.18%
OCF growth 3Y1.93%
OCF growth 5Y0.31%

ROCHE HOLDING AG-BR / RHO.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ROCHE HOLDING AG-BR?

ChartMill assigns a fundamental rating of 6 / 10 to RHO.DE.


What is the valuation status of ROCHE HOLDING AG-BR (RHO.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to ROCHE HOLDING AG-BR (RHO.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ROCHE HOLDING AG-BR?

ROCHE HOLDING AG-BR (RHO.DE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for RHO stock?

The Price/Earnings (PE) ratio for ROCHE HOLDING AG-BR (RHO.DE) is 16.95 and the Price/Book (PB) ratio is 7.97.


Is the dividend of ROCHE HOLDING AG-BR sustainable?

The dividend rating of ROCHE HOLDING AG-BR (RHO.DE) is 4 / 10 and the dividend payout ratio is 65.1%.